• Acridine Orange hydrochloride: Differential Nucleic Acid Sta

  2026-06-09

  Acridine Orange hydrochloride offers dual-fluorescence nucleic acid staining for cytochemical analyses such as cell cycle and apoptosis detection. It is best suited for applications needing a cell-permeable, high-purity dye with rapid solution use, and is not appropriate for protocols requiring long-term storage of staining solutions or non-permeant dyes.

• Kanamycin Sulfate: Water-Soluble Antibiotic in Microbiology

  2026-06-08

  Kanamycin Sulfate empowers precision selection and robust antibiotic resistance research, standing out for its solubility and reliability in microbiology assays. This guide details advanced workflows, troubleshooting, and the latest research-driven innovations with direct, actionable protocol parameters.

• Morin: Bridging Mitochondrial Modulation and Translational I

  2026-06-08

  This article explores Morin’s dual role as a mitochondrial modulator and bioanalytical probe, offering mechanistic insights and best practices for translational researchers. We examine Morin’s experimental utility, highlight its cross-domain potential, and provide actionable protocol guidance, uniquely contextualizing its relevance to complex disease modeling and clinical translation.

• Masitinib (AB1010): Technical Use in KIT/PDGFR Inhibition Wo

  2026-06-07

  Masitinib (AB1010) is a phenylaminothiazole-type tyrosine kinase inhibitor designed for selective inhibition of KIT, PDGFRα, and PDGFRβ in cellular and in vivo models. This product is best suited for DMSO-based workflows targeting cancer, mastocytosis, or inflammatory disease pathways, and is not appropriate for studies requiring broad-spectrum kinase inhibition or aqueous/ethanol solubility.

• Early-Life Pheromone Sensing Drives Adult Neurodegeneration

  2026-06-06

  Peng et al. (2023) demonstrate that early exposure to specific pheromones in C. elegans remodels neurodevelopment, triggering insulin signaling and suppressing autophagy, which accelerates neurodegeneration in adulthood. This study provides mechanistic insight into how environmental chemical cues can shape long-term neuronal health and offers experimental models relevant for neurodegenerative disease research.

• MLF2 Negatively Regulates p53 to Promote Colorectal Cancer

  2026-06-05

  This study identifies MLF2 as a novel negative regulator of p53 stability in colorectal cancer, revealing its interaction with both p53 and USP7 as a key mechanism driving tumor progression. The findings provide mechanistic insight into p53 pathway modulation and highlight potential therapeutic targets for colorectal malignancies.

• Scenario-Driven Insights: ECL Chemiluminescent Substrate Det

  2026-06-05

  This article addresses common laboratory challenges in antibody detection and protein immunodetection, highlighting how the ECL Chemiluminescent Substrate Detection Kit (Enhanced) (SKU K1230) provides reproducible, ultra-sensitive results. Practical, scenario-based Q&A blocks clarify why this kit is trusted by biomedical researchers for western blot chemiluminescence detection and quantitative protein assays.

• Tivozanib (AV-951) in Oncology: Applied Protocols & Optimiza

  2026-06-04

  Tivozanib (AV-951) stands out as a next-generation, highly selective VEGFR inhibitor, offering unmatched potency in preclinical oncology models. This article distills advanced workflows, troubleshooting guidance, and the latest in vitro evaluation innovations to help researchers maximize data quality and translational relevance.

• FH1 Small Molecule: Optimizing iPS Cell Differentiation to H

  2026-06-04

  FH1, a small molecule from APExBIO, uniquely enhances the maturation and function of iPS cell-derived hepatocytes, setting new standards for reproducible liver cell models. This article details actionable workflows, protocol optimizations, and troubleshooting strategies for integrating FH1 into advanced hepatic research.

• BRCA2 Shields RAD51 Filaments from PARP Inhibitor Disruption

  2026-06-03

  This study elucidates a previously uncharacterized protective role of BRCA2 in maintaining RAD51 filament stability by preventing PARP1 retention during PARP inhibitor (PARPi) therapy. These findings clarify the molecular basis of selective cytotoxicity in BRCA2-deficient, homologous recombination-deficient cancers and have practical implications for the design of targeted DNA repair deficiency treatments.

• Clasto-Lactacystin β-lactone: Precision Tools for Decoding V

  2026-06-03

  Explore how Clasto-Lactacystin β-lactone, a potent proteasome inhibitor, empowers next-generation research at the intersection of viral immunity and regulated cell death. This article delivers a unique, evolutionary perspective on ubiquitin-proteasome pathway manipulation for advanced assay design.

• Ganetespib (STA-9090): Redefining Hsp90 Inhibition in Cancer

  2026-06-02

  Explore how Ganetespib (STA-9090), a potent Hsp90 inhibitor, is advancing cancer research through unique chaperone disruption mechanisms and implications for innovative assay design. This article provides new insights beyond standard workflows, contrasting prior scenario-based and translational oncology perspectives.

• Morin: Multifunctional Flavonoid for Neuroprotective Researc

  2026-06-02

  Explore how Morin, a natural flavonoid, advances neuroprotective and cardioprotective research through unique mechanisms such as AMPD inhibition and fluorescent ion chelation. Discover new assay strategies and practical insights not covered in standard reviews.

• In Vitro Efficacy of Midecamycin as an Acetoxy-Substituted M

  2026-06-01

  The reference study systematically evaluated midecamycin, an acetoxy-substituted macrolide antibiotic, for its in vitro activity against a broad spectrum of Gram-positive and Gram-negative bacteria. The findings clarify midecamycin's selective efficacy and resistance profile, providing critical data for researchers designing antibacterial assays and resistance studies.

• Efficient Synthesis of Deuterium-Labeled Degarelix Acetate

  2026-06-01

  This study introduces a practical, high-yield method for synthesizing deuterium-labeled degarelix acetate, a third-generation GnRH receptor antagonist vital for clinical pharmacokinetic studies. The workflow leverages D2O/D3PO4 as a deuterium source and provides robust characterization, facilitating future absorption, distribution, metabolism, and excretion (ADME) research in androgen-related diseases.

10355 records 5/691 page Previous Next 12345 下5页 Last page